Gastrointestinal Surgery at Zhongshan Hospital Shanghai | CMCS

Expert GI Surgery in Shanghai

The Department of General Surgery at Fudan University's Zhongshan Hospital is one of China's most distinguished surgical centers, with particular strength in gastrointestinal oncology, colorectal surgery, gastric surgery, and pancreatic surgery. Combining open surgical mastery with advanced minimally invasive and robotic techniques, the department offers comprehensive surgical care for patients with benign and malignant conditions of the esophagus, stomach, small bowel, colon, rectum, and pancreas.

For international patients seeking expert GI surgical care in Shanghai, China Medical Concierge Shanghai (CMCS) provides end-to-end coordination — from medical record translation and specialist matching to on-site accompaniment and post-operative follow-up.

About the Department

Zhongshan Hospital's general surgery department is a national key clinical specialty performing thousands of GI surgical procedures annually. The department operates multiple dedicated operating theaters equipped with the latest laparoscopic and robotic surgical systems, including the da Vinci Surgical System for minimally invasive procedures requiring enhanced precision and dexterity.

A dedicated GI oncology multidisciplinary team (MDT) meets regularly to review complex cancer cases, ensuring every patient receives a personalized, evidence-based treatment plan developed collaboratively by surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists. The department also maintains close ties with Zhongshan's gastroenterology, hepatobiliary surgery, and endoscopy teams, enabling seamless management of patients with overlapping conditions.

Conditions Treated

• Colorectal Cancer — Laparoscopic and robotic colectomy, anterior resection, abdominoperineal resection (APR), and total mesorectal excision (TME) for rectal cancer
• Gastric Cancer — Total and subtotal gastrectomy with D2 lymphadenectomy, including laparoscopic and robotic approaches
• Esophageal Cancer — Minimally invasive esophagectomy (MIE) and open Ivor Lewis and McKeown procedures
• Pancreatic Cancer & Cystic Tumors — Pancreaticoduodenectomy (Whipple), distal pancreatectomy, and total pancreatectomy
• Rectal Cancer with Neoadjuvant Therapy — Multidisciplinary management including preoperative chemoradiation and watch-and-wait protocols for complete responders
• Gastrointestinal Stromal Tumors (GIST) — Surgical resection and imatinib therapy coordination
• Small Bowel Tumors & Crohn's Disease — Resection and strictureplasty for complicated small bowel disease
• Appendiceal Tumors & Pseudomyxoma Peritonei — Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
• Peritoneal Metastases — Selected cases of colorectal and gastric peritoneal metastases treated with CRS-HIPEC
• Benign Colorectal Conditions — Diverticular disease, volvulus, and complex fistula-in-ano
• Inflammatory Bowel Disease Surgery — Colectomy and ileal pouch-anal anastomosis (IPAA) for ulcerative colitis; resection for Crohn's disease complications
• Hernia Surgery — Laparoscopic and open repair of inguinal, incisional, and complex abdominal wall hernias
• Obesity & Metabolic Surgery — Laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass for morbid obesity and type 2 diabetes

Leading Specialist

Prof. Qin Xinyu (秦新裕) — Former Director, General Surgery

Prof. Qin Xinyu is one of China's most eminent gastrointestinal surgeons and a nationally recognized authority in colorectal and gastric cancer surgery. As former Director of the Department of General Surgery at Zhongshan Hospital, Prof. Qin built the department into one of China's leading GI surgical centers over decades of clinical leadership and academic contribution.

Prof. Qin is particularly renowned for his expertise in rectal cancer surgery, having championed the adoption of total mesorectal excision (TME) — the gold-standard technique for rectal cancer resection — across China. His advocacy for oncological precision, sphincter preservation, and quality-of-life outcomes in rectal cancer surgery has influenced surgical practice and training programs nationwide.

He has extensive experience in complex colorectal cases including locally advanced rectal cancer requiring multivisceral resection, recurrent rectal cancer, and patients who have undergone prior pelvic surgery or radiation. His gastric cancer program has similarly been recognized for its adherence to D2 lymphadenectomy standards and its outcomes in both open and minimally invasive gastrectomy.

Prof. Qin has served on the editorial boards of multiple Chinese and international surgical journals and has been a key contributor to national colorectal and gastric cancer surgery guidelines. He continues to be involved in clinical practice and mentorship at Zhongshan Hospital.

Surgical Approaches & Technology

Minimally Invasive Surgery

• Laparoscopic Colorectal Surgery — Right and left hemicolectomy, sigmoid colectomy, anterior resection, and APR using laparoscopic techniques with enhanced recovery protocols
• Robotic Rectal Surgery — da Vinci robotic TME for mid and low rectal cancer, offering superior visualization in the narrow pelvis
• Laparoscopic Gastrectomy — Laparoscopic total and subtotal gastrectomy with D2 dissection for gastric cancer
• Minimally Invasive Esophagectomy (MIE) — Thoracoscopic and laparoscopic esophagectomy for esophageal cancer
• Laparoscopic Pancreatic Surgery — Laparoscopic distal pancreatectomy and selected laparoscopic Whipple procedures
• Single-Incision & NOTES Techniques — Selected procedures using reduced-port or natural orifice approaches

Oncological Surgery

• Total Mesorectal Excision (TME) — Precise anatomical dissection for optimal rectal cancer clearance and sphincter preservation
• D2 Gastrectomy — Extended lymph node dissection for gastric cancer following Japanese and Korean evidence-based standards
• Multivisceral Resection — En bloc resection of locally advanced tumors involving adjacent organs
• Cytoreductive Surgery (CRS) with HIPEC — For selected patients with peritoneal metastases from colorectal or gastric primary tumors
• Transanal Total Mesorectal Excision (TaTME) — Transanal approach for low rectal cancer in challenging anatomical situations

Enhanced Recovery After Surgery (ERAS)

Zhongshan's GI surgery team follows evidence-based ERAS protocols for all major GI procedures, incorporating multimodal analgesia, early mobilization, optimized fluid management, and early oral nutrition to minimize complications and accelerate recovery. International patients can typically expect shorter hospital stays and faster return to normal activity compared to traditional surgical care pathways.

Why International Patients Choose Zhongshan GI Surgery

• Oncological Excellence — Adherence to international standards for TME, D2 gastrectomy, and multimodal cancer treatment
• Minimally Invasive Expertise — High-volume laparoscopic and robotic GI surgery with proven outcomes
• Multidisciplinary GI Oncology — Regular MDT tumor board ensuring personalized, evidence-based treatment planning
• HIPEC Capability — One of a limited number of centers in China offering CRS-HIPEC for peritoneal metastases
• ERAS Protocols — Faster recovery and reduced complications through structured perioperative care
• Cost-Effectiveness — World-class GI surgery at significantly lower cost than equivalent care in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your diagnosis, pathology reports, CT/MRI scans, colonoscopy findings, and prior treatment history with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate GI surgeon based on your specific condition and surgical needs.
4. Priority Scheduling — We secure a consultation and, where appropriate, a surgical slot with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Zhongshan Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication with your surgical team.
7. Surgical Admission Support — Full coordination of pre-operative testing, anesthesia consultation, admission, and inpatient care.
8. Post-Operative Follow-Up — Pathology report translation, discharge summary preparation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert gastrointestinal surgery in Shanghai — whether for colorectal cancer, gastric cancer, pancreatic surgery, or a complex GI condition — CMCS can arrange a specialist consultation with Zhongshan Hospital's general surgery team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com